Protective and therapeutic effects of apigenin on thioacetamide-induced hepatotoxicity in male rats: physiological and morphological study

Egyptian Liver Journal

Table 2 Comparison of hematological changes in different studied groups

Groups	WBC (10^3/uL)	RBC (10^6/uL)	HBG (g/dL)	HCT (%)	Platelets (10^3/uL)
Control (G1)	12.34±0.68	8.71±0.37	17.25±0.39	46.23±0.50	964.43±14.72
TAA (G2)	27.42±2.16^***	5.85±0.61^***	8.00±0.70^***	33.80±2.80^***	466.00±14.96^***
API (G3)	12.92±0.36^###	8.92±0.19^###	17.58±0.48^###	48.04±0.75^###	1051.14±35.19^###
TAA+API (G4)	12.45±0.58^###	8.66±0.87^###	16.37±0.38^###	45.00±1.14^###	1008.71±34.89^###
TAA+SL (G5)	13.15±0.44^###	8.39±0.44^##	16.66±0.55^###	44.37±1.20^###	1001.14±30.53^###
API+ TAA (G6)	17.71±0.67^**,###	8.17±0.52^##	15.56±0.53^###	46.03±1.61^###	635.86±80.24^***
SL+ TAA (G7)	19.45±0.91^***,###	7.91±0.41^#	12.51±0.82^***,###	46.37±0.69^###	518.43±53.52^***

^*significance versus control (G1); ^#significance versus TAA (G2); ^*P <0.050 versus control (G1); ^**P <0.010 versus control (G1); ^***P <0.001 versus control (G1); ^#P <0.050 versus TAA (G2); ^##P <0.010 versus TAA (G2); ^###P <0.001 versus TAA (G2)